128 related articles for article (PubMed ID: 23935870)
1. Impact of HIV-associated conditions on mortality in people commencing anti-retroviral therapy in resource limited settings.
Marshall CS; Curtis AJ; Spelman T; O'Brien DP; Greig J; Shanks L; du Cros P; Casas EC; da Fonseca MS; Athan E; Elliott JH
PLoS One; 2013; 8(7):e68445. PubMed ID: 23935870
[TBL] [Abstract][Full Text] [Related]
2. Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings.
Curtis AJ; Marshall CS; Spelman T; Greig J; Elliot JH; Shanks L; Du Cros P; Casas EC; Da Fonseca MS; O'Brien DP
PLoS One; 2012; 7(12):e52019. PubMed ID: 23284857
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
Alvarez-Uria G; Naik PK; Pakam R; Midde M
Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
[TBL] [Abstract][Full Text] [Related]
4. Estimated mortality on HIV treatment among active patients and patients lost to follow-up in 4 provinces of Zambia: Findings from a multistage sampling-based survey.
Holmes CB; Sikazwe I; Sikombe K; Eshun-Wilson I; Czaicki N; Beres LK; Mukamba N; Simbeza S; Bolton Moore C; Hantuba C; Mwaba P; Phiri C; Padian N; Glidden DV; Geng E
PLoS Med; 2018 Jan; 15(1):e1002489. PubMed ID: 29329301
[TBL] [Abstract][Full Text] [Related]
5. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
[TBL] [Abstract][Full Text] [Related]
6. Predictors of mortality in adult people living with HIV on antiretroviral therapy in Nepal: A retrospective cohort study, 2004-2013.
Angdembe MR; Rai A; Bam K; Pandey SR
PLoS One; 2019; 14(4):e0215776. PubMed ID: 31013320
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for mortality during antiretroviral therapy in older populations in resource-limited settings.
O'Brien D; Spelman T; Greig J; McMahon J; Ssonko C; Casas E; Mesic A; Du Cros P; Ford N
J Int AIDS Soc; 2016; 19(1):20665. PubMed ID: 26782169
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programs.
Grimsrud A; Balkan S; Casas EC; Lujan J; Van Cutsem G; Poulet E; Myer L; Pujades-Rodriguez M
J Acquir Immune Defic Syndr; 2014 Oct; 67(2):e55-66. PubMed ID: 24977472
[TBL] [Abstract][Full Text] [Related]
9. Similar mortality and reduced loss to follow-up in integrated compared with vertical programs providing antiretroviral treatment in sub-saharan Africa.
Greig J; O'Brien DP; Ford N; Spelman T; Sabapathy K; Shanks L
J Acquir Immune Defic Syndr; 2012 Apr; 59(5):e92-8. PubMed ID: 22134144
[TBL] [Abstract][Full Text] [Related]
10. Survival and determinants of mortality in adult HIV/Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia.
Damtew B; Mengistie B; Alemayehu T
Pan Afr Med J; 2015; 22():138. PubMed ID: 26889319
[TBL] [Abstract][Full Text] [Related]
11. Pre-ART nutritional status and its association with mortality in adult patients enrolled on ART at Fiche Hospital in North Shoa, Oromia region, Ethiopia: a retrospective cohort study.
Tesfamariam K; Baraki N; Kedir H
BMC Res Notes; 2016 Dec; 9(1):512. PubMed ID: 27998310
[TBL] [Abstract][Full Text] [Related]
12. Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting.
Clouse K; Pettifor A; Maskew M; Bassett J; Van Rie A; Gay C; Behets F; Sanne I; Fox MP
AIDS; 2013 Feb; 27(4):645-50. PubMed ID: 23169326
[TBL] [Abstract][Full Text] [Related]
13. Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study.
Silverman RA; John-Stewart GC; Beck IA; Milne R; Kiptinness C; McGrath CJ; Richardson BA; Chohan B; Sakr SR; Frenkel LM; Chung MH
PLoS One; 2019; 14(10):e0223411. PubMed ID: 31584992
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for unstructured treatment interruptions and association with survival in low to middle income countries.
McMahon JH; Spelman T; Ford N; Greig J; Mesic A; Ssonko C; Casas EC; O'Brien DP
AIDS Res Ther; 2016; 13():25. PubMed ID: 27408611
[TBL] [Abstract][Full Text] [Related]
15. Physicians' patient base composition and mortality among people living with HIV who initiated antiretroviral therapy in a universal care setting.
Allan B; Closson K; Collins AB; Kibel M; Pan S; Cui Z; McLinden T; Parashar S; Lima VD; Chia J; Yip B; Barrios R; Montaner JSG; Hogg RS
BMJ Open; 2019 Mar; 9(3):e023957. PubMed ID: 30898806
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
[TBL] [Abstract][Full Text] [Related]
17. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
[TBL] [Abstract][Full Text] [Related]
18. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania.
Johannessen A; Naman E; Ngowi BJ; Sandvik L; Matee MI; Aglen HE; Gundersen SG; Bruun JN
BMC Infect Dis; 2008 Apr; 8():52. PubMed ID: 18430196
[TBL] [Abstract][Full Text] [Related]
19. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa.
Asiimwe SB; Kanyesigye M; Bwana B; Okello S; Muyindike W
BMC Infect Dis; 2016 Feb; 16():43. PubMed ID: 26832737
[TBL] [Abstract][Full Text] [Related]
20. Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.
Pujades-Rodríguez M; Balkan S; Arnould L; Brinkhof MA; Calmy A;
JAMA; 2010 Jul; 304(3):303-12. PubMed ID: 20639564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
